Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients.
about
Cortisol is an associated-risk factor of brain dysfunction in patients with severe sepsis and septic shockBiochemical markers of neurodegeneration in hereditary diffuse leucoencephalopathy with spheroids.Modulation of myelin basic protein gene expression by acetyl-L-carnitine.The neuroprotective effect of picroside II via regulating the expression of myelin basic protein after cerebral ischemia injury in ratsIncreased sleep need and daytime sleepiness 6 months after traumatic brain injury: a prospective controlled clinical trial.Blood biomarkers of ischemic stroke.Prognostic value of cerebrospinal fluid free fatty acid levels in patients with acute ischemic stroke.Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neuronesMyelin basic protein and ischemia modified albumin levels in acute ischemic stroke cases.Current status of fluid biomarkers in mild traumatic brain injuryGlatiramer acetate in treatment of multiple sclerosis: a toolbox of random co-polymers for targeting inflammatory mechanisms of both the innate and adaptive immune system?Effect of Tempol on Cerebral Resuscitation Caused by Asphyxia-Induced Cardiac Arrest.The promise and potential pitfalls of serum biomarkers for ischemic stroke and transient ischemic attackThe neonatal levels of TSB, NSE and CK-BB in autism spectrum disorder from Southern ChinaSelected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease.Molecular biomarkers in stroke diagnosis and prognosis.Potential biomarkers for the diagnosis of stroke.Capacity of Human Dental Follicle Cells to Differentiate into Neural Cells In Vitro.The proteomic toolbox for studying cerebrospinal fluid.Sepsis-associated encephalopathy.Ischemic stroke biomarkers in blood.Biomarkers of cerebral injury and inflammation in pediatric tuberculous meningitis.Peripheral biomarkers of stroke: Focus on circulatory microRNAsThe role of magnesium sulfate in the intensive care unit.Discriminatory Analysis of Biochip-Derived Protein Patterns in CSF and Plasma in Neurodegenerative Diseases.Preparation of synaptic plasma membrane and postsynaptic density proteins using a discontinuous sucrose gradient.Glial S100B is elevated in serum across the spectrum of West Nile virus infection.Plasma homocysteine concentration and its relation to symptoms of vascular disease in psychogeriatric patients.Glial fibrillary acidic protein as a prognostic marker of acute ischemic stroke.Effect of magnesium on functional outcome and paraclinical parameters of patients undergoing supratentorial craniotomy for brain tumors: a randomized controlled trial.Injection of ropivacaine into the subarachnoid changes the ultrastructure and proteome of the rat spinal cord.Levels of neuroglobin in serum and neurocognitive impairments in Chinese patients with obstructive sleep apnea.Time-dependent changes of protein biomarker levels in the cerebrospinal fluid after blast traumatic brain injury.Increased GFAP and S100beta but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severity.Neurospecific proteins in the serum of patients with brain tumors.Microtubule-associated protein 2, an early blood marker of ischemic brain injury.Effects of Kudiezi Injection on Serum Inflammatory Biomarkers in Patients with Acute Cerebral Infarction
P2860
Q33616353-774E03B1-5B1E-404A-AD1C-192F626E4B3DQ33743009-1AA26E79-60FF-4BC0-9C11-E9BAD5C0D6F9Q33912560-726F613B-FD6F-4B5D-9783-FFAA373B1CB1Q35093865-61BC97DB-8720-449D-86FE-27C0BE9FA1DBQ35533955-5E5961AC-C163-4161-B11F-9AE66102DAB7Q35648087-E184CC04-814F-4F35-9DB5-83F910611E04Q35847664-8BA9E006-E451-46A6-A069-D783CB07AC18Q36141873-F5218CB2-686D-495C-B16E-4AA69BFA6382Q36270112-E74648BC-2BDC-425C-8AB2-8E3CEB913600Q36424343-9DAD583F-37CE-4C96-ACEB-AE661E8DB2EBQ36432500-9BC13B88-E933-4774-A03A-9B27E9D6B774Q36721484-B6014ECE-4F2E-4A9D-AC28-974BD5703FB8Q37212726-21ADA9D9-1CDF-4714-8779-F23E15C8238BQ37245265-5072E64D-B4B9-4A43-8E1C-19E92ED0F768Q37296047-24DEF07A-2207-4690-B7CF-54A5FCF4336AQ37408830-C618EF65-4483-4384-AA9B-DCBFDFB6095CQ37451522-3BACE5E6-34F5-40F1-A33C-A6C2D0A80B55Q37651545-747ABBA9-55F7-46F9-A938-14285F100E38Q37998531-2D6BFF6D-E9BA-4027-9641-A6CBBC09A4A7Q38044198-A0882E47-6D05-4C9F-A809-232006E3FB06Q38079618-CB26FB13-522B-4704-821E-47E026347AC5Q38729907-BD2F4E3E-C0A0-48D6-98D8-278388701F6DQ38922418-FE1B58B6-6BD3-42A5-91F1-3A58AB558343Q39427028-649613A9-A900-423B-96EC-69684720BA86Q39767184-8AE20BFE-62A6-4B4B-B172-4C965A3D3427Q40043676-80CBBB51-127B-470F-BAF8-21BD53C7C6E2Q40287128-3F4240EC-9CAA-469F-8EB8-F116299EEE65Q46439023-8155C44B-C68F-41DA-8B33-D1213B41AC09Q47225523-69129112-EEE7-42BB-A20E-F0752AA3EAA8Q47728391-87700F97-F1A1-4B23-BF6D-761901E016CAQ48022550-9C8866AA-65AD-4144-9C4B-761ACD5F1C25Q48239683-8D7E4136-8746-4317-8CC7-981456D13FEAQ48290236-73569FE8-E36D-4168-89FB-F4D9775871A8Q48488968-69A3C8CF-A298-4D38-9F98-9EBE173A0403Q48717903-A7033B57-16F7-42A6-A512-6F054FAD33DCQ48879204-F668D834-F06A-474A-AA82-C65423755E6DQ58770084-3F3EE8B1-1115-4476-8942-2F1CF99F20AD
P2860
Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Protein S-100B, neuron-specifi ...... lood of neurological patients.
@ast
Protein S-100B, neuron-specifi ...... lood of neurological patients.
@en
type
label
Protein S-100B, neuron-specifi ...... lood of neurological patients.
@ast
Protein S-100B, neuron-specifi ...... lood of neurological patients.
@en
prefLabel
Protein S-100B, neuron-specifi ...... lood of neurological patients.
@ast
Protein S-100B, neuron-specifi ...... lood of neurological patients.
@en
P2093
P1476
Protein S-100B, neuron-specifi ...... lood of neurological patients.
@en
P2093
Rosmalen F
Verbeek MM
van Engelen BG
van Geel WJ
P304
P356
10.1016/S0361-9230(03)00089-3
P577
2003-08-01T00:00:00Z